Reply to “Misleading Title and Communication Regarding Brief Communication entitled: First clinical use of real‐time remote programming in cardiac implantable electronic devices”

Author(s):  
Toshimasa Okabe ◽  
Muhammad R. Afzal ◽  
John D. Hummel ◽  
Emile G. Daoud ◽  
Mahmoud Houmsse ◽  
...  
2020 ◽  
Vol 31 (10) ◽  
pp. 2759-2761
Author(s):  
Toshimasa Okabe ◽  
Muhammad R. Afzal ◽  
John D. Hummel ◽  
Emile G. Daoud ◽  
Mahmoud Houmsse ◽  
...  

Author(s):  
Patrick Zardo ◽  
Henning Busk ◽  
Johannes Hadem ◽  
Hassina Baraki ◽  
George Kensah ◽  
...  

Objective Even though roughly 90% of all implanted cardiac implantable electronic devices leads can be removed through conventional techniques, presence of large vegetations or thrombi, fractured leads, previous failed extraction, or long duration from implantation often impede classical transvenous extraction. In these cases, laser-assisted procedures represent a highly successful alternative and have a low procedural complication rate with major adverse events in less than 2% of cases. Unfortunately, most encountered complications are potentially fatal, which prompted us to develop a novel approach that adds additional safety measures by allowing for real-time intrathoracic visualization and intervention. Methods Five consecutive patients classified as high-risk patients received concomitant laser sheet extraction and right-sided uniportal video-assisted thoracic surgery for real-time intrathoracic visualization. Results Complete extraction was achieved in all cases without observing major intraoperative events, and on-table extubation was feasible in all cases. No chest tube-associated or incision-related complications were encountered. Conclusions Concomitant laser sheet extraction and video-assisted thoracoscopy are feasible and may offer benefits in high-risk patients. Further studies to document the actual safety and clinical value of our procedure are warranted.


2013 ◽  
Vol 4 (7) ◽  
pp. 1320-1324
Author(s):  
ESTEBAN KLOOSTERMAN ◽  
MURRAY ROSENBAUM ◽  
EVAN GOLDSTEIN ◽  
JAIME ALVAREZ ◽  
TERRY COHEN ◽  
...  

2011 ◽  
Vol 3 (1) ◽  
pp. 74
Author(s):  
Kathy L Lee ◽  

Cardiac pacemakers have been the standard therapy for patients with bradyarrhythmias for several decades. The pacing lead is an integral part of the system, serving as a conduit for the delivery of energy pulses to stimulate the myocardium. However, it is also the Achilles’ heel of pacemakers, being the direct cause of most device complications both acutely during implant and chronically years afterwards. Leadless pacing with ultrasound-mediated energy has been demonstrated in animals and humans to be safe and feasible in acute studies. Implantable defibrillators revolutionised the treatment and prevention of sudden cardiac death. Subcutaneous implantable defibrillators have been under development for more than 10 years. A permanent implantable system has been shown to be feasible in treating induced and spontaneous ventricular tachyarrhythmias. These developments and recent advances in pacing and defibrillation will arouse further interest in the research and development of leadless cardiac implantable electronic devices.


Sign in / Sign up

Export Citation Format

Share Document